- Home
- AAL vs KRYS Comparison
AAL vs KRYS Comparison
Compare AAL & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAL | KRYS |
|---|---|---|
| Founded | 1930 | 2015 |
| Country | United States | United States |
| Employees | 133700 | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 10.3B |
| IPO Year | 2004 | 2017 |
Fundamental Metrics
Financial Performance| Metric | AAL | KRYS |
|---|---|---|
| Price | $18.08 | $371.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 11 |
| Target Price | $15.59 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 130.8M | 329.9K |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | N/A | ★ 1.83 |
| Revenue | ★ $54,633,000,000.00 | $389,130,000.00 |
| Revenue This Year | $12.17 | $38.74 |
| Revenue Next Year | $4.62 | $32.53 |
| P/E Ratio | ★ N/A | $206.37 |
| Revenue Growth | 0.78 | ★ 33.94 |
| 52 Week Low | $10.09 | $130.50 |
| 52 Week High | $18.05 | $378.15 |
Technical Indicators
Market Signals| Indicator | AAL | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 80.04 | 72.32 |
| Support Level | $12.20 | $246.17 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.66 | 13.58 |
| MACD | 0.24 | 4.19 |
| Stochastic Oscillator | 94.95 | 83.55 |
Price Performance
Historical ComparisonAbout AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.